Thank you @stockrock for your views. I cannot add any more weight to your views unless I turn blue in the face. But I just hope newbies will heed your wise analysis, sit up and take notice. This is as major a breakthrough for me as the iTest win because the retrofit market that SUBRE addresses is a hundred times larger than the rural segment that Aspiral is addressing. The price is muted in its response, and that is ok. But for me, it's more important to me the company continues to derisk. Well done to FLC's China team.
Fluence Signs First Commercial SUBRE Order in China, page-5
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add FLC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
-0.005(4.00%) |
Mkt cap ! $129.7M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 12.5¢ | 12.0¢ | $15.22K | 123.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 175663 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 23084 | 1 |
View Market Depth
| Last trade - 15.54pm 12/07/2024 (20 minute delay) ? |
| FLC (ASX) Chart |